This compound is the major active metabolite of the anticoagulant edoxaban. It is a pharmaceutical intermediate used in the manufacturing and research of edoxaban-related substances.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
1-bromoadamantane
pharmaceutical raw material
Amantadine
pharmaceutical raw material
Azaerythromycin a
pharmaceutical raw material
Sodium iodide
pharmaceutical raw material
2-[[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-[(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridine-2-carbonyl)amino]cyclohexyl]amino]-2-oxoacetic acid
CIKVHUDEOYKYGJ-GMXVVIOVSA-N
CN1CCC2=C(C1)SC(=N2)C(=O)N[C@@H]3C[C@H](CC[C@@H]3NC(=O)C(=O)O)C(=O)N(C)C
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.